Literature DB >> 1184184

[Osmo-oncotherapy in brain edema].

H Gofferje, H Landgraf, W von Schwerin, K Schultis.   

Abstract

The treatment of cerebral edema must be directed towards improving the volume regulation of the brain cell which is disturbed due to reduced blood flow and hypoxia and towards restoring the disturbed function of the blood-brain barrier. Onco-osmotherapy increases the effective intracranial blood pressure difference and improves cerebral blood supply and oxygen absorption, thus exerting a positive effect on sodium concentration in the brain cell which is responsible for the intracellular corticocerebral edema. After renal excretion of the osmotherapeutic agent, however, water may again flow into the brain cell, depending on the osmotic gradient. When the function of the blood-brain barrier is disturbed, osmotherapy may lead to an undesired increase of the osmotic pressure in the tissue. In spite of this, onco-osmotherapy is one of the most effective measures in the treatment of cerebral edema. Choice of therapeutic agents, dosage, infusion rates, side effects and contraindications are dealt with in detail.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1184184

Source DB:  PubMed          Journal:  Infusionsther Klin Ernahr        ISSN: 0378-0791


  2 in total

1.  [The effect of different types of osmotic or oncotic therapy on intracranial pressure and electrical activity of the brain in experimental brain edema].

Authors:  M Gaab; O E Knoblich; J Schupp; K Dietrich; U Fuhrmeister; P Gruss
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

2.  Effect of furosemide (lasix) on acute severe experimental cerebral edema.

Authors:  M Gaab; O E Knoblich; J Schupp; F Herrmann; U Fuhrmeister; K W Pflughaupt
Journal:  J Neurol       Date:  1979-05-02       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.